MBL Wealth, LLC
Source: SEC Form 13F · as of Mar 2026MBL Wealth, LLC holds 19 biotech & pharma companies tracked by BioSniper, totaling $14.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$14.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 10,729 | $2.6M |
| LLYELI LILLY & Co | 2,422 | $2.2M |
| ABBVAbbVie Inc. | 8,846 | $1.9M |
| MRKMerck & Co., Inc. | 12,269 | $1.5M |
| CAHCardinal Health Inc. | 3,352 | $708K |
| BMYBRISTOL MYERS SQUIBB CO | 9,739 | $591K |
| AMGNAMGEN INC | 1,513 | $532K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,958 | $530K |
| PFEPFIZER INC | 17,693 | $497K |
| GILDGILEAD SCIENCES, INC. | 3,176 | $443K |
| PMPhilip Morris International Inc | 2,429 | $402K |
| REGNREGENERON PHARMACEUTICALS, INC. | 480 | $371K |
| GMOptec International, Inc. | 3,819 | $285K |
| AZNASTRAZENECA PLC | 1,376 | $271K |
| LQDALiquidia Corp | 6,847 | $258K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 557 | $249K |
| ABTABBOTT LABORATORIES | 2,216 | $228K |
| MCKMcKesson Corporation | 247 | $214K |
| NBIXNEUROCRINE BIOSCIENCES INC | 1,545 | $204K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.